>>>I was planning a much longer post but lately I

>>>I was planning a much longer post but lately I have been stupid busy<<<


Does not have to be longer WB, the content of your post was enough to warrant attention and IMO is spot on. The 3 questions you present and their answers is very pertinent and important for all investors to hear. The answers, if positive, is IMO the catalyst for the future of this company and our investments. Since it is obvious that the management's attention is now on RRX, that is what and where we should want to hear of progress. Such a powerful and exciting addition to surgical post operative procedures is this medical device, that we should not overlook the immense potential it has. How many surgeries performed worldwide? It makes too much sense for it to be accepted by MD's and used on most all surgical wounds. Why, when introduced to hospital directors (decision makers) would they not stand up and listen.

Education is the first step, as this product is without a doubt, totally unknown to surgeons. Let's hope that all those sales reps are doing their jobs and showing the benefits of using RRX post operative. And if they are, I will be listening closely for if this subject is elaborated on by KN. It has been awhile since we have heard of any progress by those hundreds of sales reps, maybe this CC is the time.

Your other two points of 'insurance coverage' and 'new manufacturer' are also spot on as to what investors want to hear. And both are very important for the success of this company and our investments. As usual, thanks for your insight,
,